Join
Live feed
·
INSIDERFilingvia Quantisnow
Apogee Therapeutics Inc. logo

Chief Executive Officer Henderson Michael Thomas sold $10,603,200 worth of shares (80,000 units at $132.54) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 1,015,987 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
APGE· Apogee Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APGE (Apogee Therapeutics Inc.) and more on Quantisnow.

Chief Executive Officer Henderson Michael Thomas sold $10,603,200 worth of shares (80,000 units at $132.54) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 1,015,987 units (SEC Form 4) | Quantisnow